Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
-
Bayport Management Ltd Standalone Financial Statements year ended December 2025
-
Bayport Management Ltd Group Audited Financial Statements year ended December 2025
-
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
-
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent
-
urban-gro, Inc. Positions for Entry into Multi-Billion-Dollar T20 Cricket Market with LPL Season Six Player Auction on May 15, 2026 via IPG Platform
-
Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan
-
PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024
-
Connect Biopharma Announces $20.2 Million Private Placement Financing
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Apollo Reports Results of Annual General Meeting and Appointment of New Executive Chair and Lead Director
-
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
-
Nearly 3 in 10 (29%) Gig Workers Risk Significant Penalties by Not Declaring Gig Income - Despite Regulations Requiring Gig Platforms to Report Workers’ Income to the CRA: H&R Block Canada Surve
-
49 new Nova LFS buses for the Greater Hamilton Area
-
Full Market Visibility Is Crucial for Winning Deals: What PE Firms Need to Know Now
-
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
-
Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
-
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
-
Priority Income Fund Announces 16.6% Annualized Total Cash Distribution Rate (on Net Asset Value) with Common Shareholder Distributions for March 2026 through May 2026
-
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
-
Guardian Capital Announces Changes to Certain of its Funds
-
Xali Gold Initiates Engineering and Permitting for both Operations and Exploration at Pico Machay Gold Project in Peru
-
CareCloud Highlights Successful Preferred A Conversion, Progress Toward Capital Structure Simplification, and Reaffirms Growth Outlook
-
Mavenir Receives the President’s Honor at MSUA’s 2026 Satellite Mobile Innovation Awards
-
Smart Share Global Limited Granted Exception by Nasdaq Staff Related to Filing of Its Interim Report
-
OROCO ANNOUNCES RESIGNATION OF CEO
-
Terrestrial Energy Announces Fourth Quarter and Full Year 2025 Results
-
Digital Realty Announces Final Close of $3.25 billion U.S. Hyperscale Data Center Fund
-
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
-
USA Rare Earth Reports Fourth Quarter and Full-Year 2025 Financial Results
-
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
-
Vireo Growth Inc. Announces Update on Non-Binding Memorandum of Understanding to Acquire The Hawthorne Gardening Company from ScottsMiracle-Gro
-
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psych
-
Amplify ETFs Declares March Income Distributions for its Income ETFs
-
49 new Nova LFS buses for the Greater Hamilton Area
-
Stanley Steemer Launches “Dirt Balls” Campaign to Reveal Cleaning Blind Spots In American Homes
-
Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
-
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
-
OTC Markets Group Welcomes BluEnergies Ltd. to OTCQX
-
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
-
AskNicely Launches Ask NiceAI®, a Breakthrough Tool to Turn Customer Feedback Into Revenue Growth
-
Oatly to Report First Quarter 2026 Financial Results on April 29, 2026
-
Changes in the Kalmar Leadership Team
-
Global Water Awards 2026: Voting Opens as Full Shortlist Is Revealed
-
Signify share repurchase periodic update
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Ellomay Capital to Sell its Indirect Holdings in Dorad Energy Ltd. based on a Dorad Valuation of NIS 4.4 Billion
-
ProVen Growth and Income VCT plc: Issue of Equity
-
ProVen VCT plc: Issue of Equity
